相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients
Ranita Kirubakaran et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review
H. E. Braithwaite et al.
TRANSPLANTATION REVIEWS (2021)
Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients
Marc Labriffe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Variability in the Log Domain and Limitations to Its Approximation by the Normal Distribution
Jeroen Elassaiss-Schaap et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients
Zheng Lu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients
Camille Riff et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
Merce Brunet et al.
THERAPEUTIC DRUG MONITORING (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Limited sampling strategy to predict the area under the curve of tacrolimus in Mexican renal transplant pediatric patients receiving Prograf® or non-innovator formulations
Lorena Medina-Aymerich et al.
PEDIATRIC TRANSPLANTATION (2019)
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients
L. M. Andrews et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
Jean-Baptiste Woillard et al.
FRONTIERS IN PHARMACOLOGY (2017)
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Thomas Vanhove et al.
DRUG METABOLISM REVIEWS (2016)
Imputation with the R Package VIM
Alexander Kowarik et al.
JOURNAL OF STATISTICAL SOFTWARE (2016)
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation
Carlos Orlando Jacobo-Cabral et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Development of a Population PK Model of Tacrolimus for Adaptive Dosage Control in Stable Kidney Transplant Patients
Franc Andreu et al.
THERAPEUTIC DRUG MONITORING (2015)
A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients
Yan-xia Lu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Lessons From Routine Dose Adjustment of Tacrolimus in Renal Transplant Patients Based on Global Exposure
Franck Saint-Marcoux et al.
THERAPEUTIC DRUG MONITORING (2013)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
分享论文
